Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects
Marine Drugs · 03.06.2026 · 24 (6) · 197
DOI: 10.3390/md24060197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 03.06.2026. Verfasst von Ana Gomes-Bispo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Aquaculture, Upgrading and Bioprospection (DivAV), Portuguese Institute for the Sea and Atmosphere (IPMA, I.P.), Av. Alfredo Magalhães Ra…. Hauptthemen laut MEDLINE: Alzheimer Disease, Lipids, Aquatic Organisms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 365 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mar 2030, European Commission, Government of Portugal.
Themen: Demenz
Abstract (Originalsprache)
Due to its high prevalence and significant impact on modern society, Alzheimer’s disease (AD) is one of the most important neurodegenerative disorders. It is more common among individuals over the age of 65, and its incidence has increased sharply as a result of rising life expectancy. Several factors have made it challenging to identify an effective treatment for AD. One major difficulty lies in its complexity, as the mechanisms involved in its progression are not yet fully understood. Nevertheless, the role of diet and lipids has been highlighted by numerous studies, underscoring their potential influence on this pathology. Due to the intricacy of its biochemical and metabolic interactions, this subject continues to be of particular interest, highlighting the need for further research. In this sense, this comprehensive and updated review aimed to elucidate these aspects, especially regarding marine-derived lipids, whose bioactive potential may become an irreplaceable tool in the management of AD, whether in terms of its treatment or prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Aquaculture, Upgrading and Bioprospection (DivAV), Portuguese Institute for the Sea and Atmosphere (IPMA, I.P.), Av. Alfredo Magalhães Ramalho, 6, 1495-165 Algés, Portugal.
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal.
ORCID-Profile: Ana Gomes-Bispo, Carlos Cardoso, Cláudia Afonso, Helena Maria Lourenço, Sónia Pedro, Narcisa M Bandarra
Förderung
- Mar 2030
- European Commission
- Government of Portugal
- GENEMARE_PORTUGAL “Biobanco Azul—Banco Nacional dos Recursos Vivos Marinhos”
- FISHEUTRUST
- Pacto Bioeconomia Azul—Vertical Bivalves projects
Zitieren
APA
Gomes-Bispo, A., Cardoso, C., Afonso, C., Lourenço, H. M., Pedro, S., Moniz, P., & Bandarra, N. M. (2026). Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects. Marine Drugs, 24(6), 197. https://doi.org/10.3390/md24060197
Vancouver
Gomes-Bispo A, Cardoso C, Afonso C, Lourenço HM, Pedro S, Moniz P, et al. Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects. Marine Drugs. 2026;24(6):197. doi:10.3390/md24060197
BibTeX
@article{GomesBispo2026,
author = {Gomes-Bispo, Ana and Cardoso, Carlos and Afonso, Cláudia and Lourenço, Helena Maria and Pedro, Sónia and Moniz, Patrícia and Bandarra, Narcisa M},
title = {Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {6},
pages = {197},
doi = {10.3390/md24060197}
}
EUVIMED